surmount tirzepatide trials after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Tirzepatide as Compared with Semaglutide
Description
Potential Cardiovascular Benefits: Early studies suggest that Tirzepatide may offer cardiovascular benefits, including reduced risk factors for heart disease, although more research is needed to confirm these effects
If assistance is needed, they should reach out to their healthcare provider for guidance
A habit and motivation engine carries you through the early window where most people quit
[1] [2] The pivotal SUSTAIN trials, which evaluated semaglutide for type 2 diabetes, and the STEP trials for weight management did not identify cold intolerance as a statistically significant adverse event
